UK spin‑out speeds up development and reduces animal testing A UK biotech company has launched what it describes as a world‑first platform of lab‑grown human muscle designed to give drug developers ...
Boehringer Ingelheim has reported positive topline results from the phase III SYNCHRONIZE‑1 trial, showing that its ...
Collaboration aims to create integrated platform from discovery to IND submission BioDuro has entered a strategic partnership with CTI Biotechnology to build an integrated preclinical development ...
Kahimmune Therapeutics has signed a scientific collaboration agreement with Gustave Roussy to support the selection and development of its first shared mRNA companion neoantigen therapy candidate, KAH ...
David Apelian, CEO of Theolytics, said: “We are proud to announce the dosing of the first patient in this important study.” ...
The UK’s Medicines & Healthcare Products Regulatory Agency has granted marketing authorisation to Enflonsia (clesrovimab), ...
AstraZeneca’s Saphnelo has been approved in the US for self‑administration as a once‑weekly autoinjector, the Saphnelo Pen, ...
Asgard Therapeutics will present new preclinical data on its lead asset AT‑108 in an oral presentation at the ASGCT Annual Meeting, taking place from 11–15 May in Boston. AT‑108 is a first‑in‑class, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results